Brought to you by 
Sanofi buys Fovea for €370mm in cash and earn-outs
08 Oct 2009
Executive Summary
Sanofi-Aventis will pay €370mm ($541mm) to acquire all of privately held French ophthalmics company Fovea Pharmaceuticals SA. According to the companies, the purchase price includes a significant amount up front (which Elsevier Business Intelligence estimates at about 25%) and the remainder in development-based earn-outs.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com